Hanna Mandel
Hanna Mandel has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Tzipora C. Falik Zaccai
Institute of Human Genetics, Galilee Medical Center, Nahariya, Israel
3 shared publications Limor Kalfon
Institute of Human Genetics Galilee Medical Center Nahariya Israel
2 shared publicationsAlon Yulevich
Department of Pediatric Surgery Galilee Medical Center Nahariya Israel
1 shared publicationAyalla Fedida
Institute of Human Genetics, Galilee Medical Center, Nahariya, Israel; The Azrieli Faculty of Medicine, Bar-Ilan, Safed, Israel
1 shared publicationAyelet Eran
Neuroradiology Rambam Health Care Campus, and Technion Faculty of Medicine Haifa Israel
1 shared publicationD. Lumelski
1 shared publication
Latest Publications
- Open Access
- 7 January 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (4) , 101682
Tyrosine supplementation with high-protein diet as a therapeutic strategy for YARS1 deficiency
- 7 January 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (4) , 101682
Open AccessTyrosine supplementation with high-protein diet as a therapeutic strategy for YARS1 deficiency
- Open Access
- 31 December 2021
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (1) , e1849
Congenital Hypotonia: Cracking a SAGA of consanguineous kindred harboring four genetic variants
Background: We aimed to determine the molecular and biochemical basis of an extended highly consanguineous family with multiple children presenting severe congenital hypotonia.Methods: Clinical investigations, homozygosity mapping, linkage analyses and whole exome sequencing, were performed. mRNA and protein levels were determined. Population screening was followed.Results: We have identified a novel nonsense variant in NGLY1 in two affected siblings, and compound heterozygosity for three novel RYR1 variants in two affected sisters from another nuclear family within the broad pedigree. Population screening revealed a high prevalence of carriers for both diseases. The genetic variants were proven to be pathogenic, as demonstrated by western blot analyses.Conclusions: Revealing the genetic diagnosis enabled us to provide credible genetic counselling and pre‐natal diagnosis to the extended family and genetic screening for this high‐risk population. Whole exome/genome sequencing should be the first tier tool for accurate determination of the genetic basis of congenital hypotonia. Two different genetic disorders within a large consanguineous pedigree should be always considered.
- 31 December 2021
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (1) , e1849
Open AccessCongenital Hypotonia: Cracking a SAGA of consanguineous kindred harboring four genetic variants
Background: We aimed to determine the molecular and biochemical basis of an extended highly consanguineous family with multiple children presenting severe congenital hypotonia.Methods: Clinical investigations, homozygosity mapping, linkage analyses and whole exome sequencing, were performed. mRNA and protein levels were determined. Population screening was followed.Results: We have identified a novel nonsense variant in NGLY1 in two affected siblings, and compound heterozygosity for three novel RYR1 variants in two affected sisters from another nuclear family within the broad pedigree. Population screening revealed a high prevalence of carriers for both diseases. The genetic variants were proven to be pathogenic, as demonstrated by western blot analyses.Conclusions: Revealing the genetic diagnosis enabled us to provide credible genetic counselling and pre‐natal diagnosis to the extended family and genetic screening for this high‐risk population. Whole exome/genome sequencing should be the first tier tool for accurate determination of the genetic basis of congenital hypotonia. Two different genetic disorders within a large consanguineous pedigree should be always considered.
- 1 August 2021
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 64 (8) , 104249
Concomitant congenital CMV infection and inherited liver diseases
- 1 August 2021
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 64 (8) , 104249
Concomitant congenital CMV infection and inherited liver diseases
- 1 November 2020
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 63 (11) , 104020
Sedaghatian-type spondylometaphyseal dysplasia: Whole exome sequencing in neonatal dry blood spots enabled identification of a novel variant in GPX4
- 1 November 2020
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 63 (11) , 104020
Sedaghatian-type spondylometaphyseal dysplasia: Whole exome sequencing in neonatal dry blood spots enabled identification of a novel variant in GPX4
- 1 January 2005
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 18 (6) , 617-620
Secondary Diabetes Mellitus: Late Complication of Glycogen Storage Disease Type 1b
We report a 22 year-old male with glycogen storage disease type 1 (GSD-1) who developed diabetes mellitus secondary to pancreatic islet beta-cell insufficiency. Diabetes mellitus should be considered among the late complications of GSD-1. The pathogenesis of the conversion, from a disease characterized by hypoglycemia to a disease dominated by hyperglycemia, is discussed.
- 1 January 2005
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 18 (6) , 617-620
Secondary Diabetes Mellitus: Late Complication of Glycogen Storage Disease Type 1b
We report a 22 year-old male with glycogen storage disease type 1 (GSD-1) who developed diabetes mellitus secondary to pancreatic islet beta-cell insufficiency. Diabetes mellitus should be considered among the late complications of GSD-1. The pathogenesis of the conversion, from a disease characterized by hypoglycemia to a disease dominated by hyperglycemia, is discussed.
- Open Access
- 1 June 1995
- Published by Elsevier in Journal of Lipid Research
- Vol. 36 (6) , 1385-1391
Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis.
- 1 June 1995
- Published by Elsevier in Journal of Lipid Research
- Vol. 36 (6) , 1385-1391
Open AccessReduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis.